We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Intelligent Ultrasound Group Plc | LSE:MED | London | Ordinary Share | GB00BN791Q39 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 14.50 | 14.00 | 15.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMMED
RNS Number : 6265N
Medaphor Group PLC
10 August 2017
10 August 2017
MedaPhor Group plc
("MedaPhor" the "Company")
Payment of deferred consideration
On 3 August 2016, MedaPhor Group plc (AIM: MED), the global provider of advanced ultrasound skills training simulators for medical professionals, announced the acquisition of Inventive Medical Limited ("IML"). Further to the terms of the acquisition, 2,325,582 new ordinary shares are being issued to The Incorporated Trustees of University College London Hospitals Charities (the "Retention Shares"). The issue of the Retention Shares was contingent on no seller warranty or indemnity breaches (as specified in the IML Sale and Purchase Agreement) arising during the 12 month period following the acquisition. The directors can confirm no seller warranty or indemnity breaches have occurred.
Application has been made for admission of the Retention Shares to be admitted to trading on the AIM market of the London Stock Exchange ("Admission") and it is expected that Admission will become effective on 16 August 2017. Following Admission the total number of voting rights of the Company's Ordinary Shares will be 34,224,158.
Enquiries:
Hot Features
Premium
MedaPhor Group plc www.medaphor.com
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Cenkos Securities Tel: +44 (0)20 7397 8900
Bobbie Hilliam (Nominated
Adviser)
Walbrook PR Tel: +44 (0)20 7933 8780
or medaphor@walbrookpr.com
Paul McManus / Anna Mob: +44 (0)7980 541 893
Dunphy / Mob: +44 (0)7876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUROBRBUAWARR
(END) Dow Jones Newswires
August 10, 2017 03:37 ET (07:37 GMT)
1 Year Intelligent Ultrasound Chart |
1 Month Intelligent Ultrasound Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
